More than 25,000 bottles of chlorthalidone blood pressure medication have been recalled in the United States after the tablets failed safety tests. Patients are being advised to contact their pharmacist to check whether their medication is affected.
Two recalls from the same manufacturer
Inventia Healthcare Limited voluntarily initiated the recall through the Food and Drug Administration (FDA) on September 3. That recall covered 13,567 bottles of 25mg chlorthalidone tablets. In June, the same firm recalled 11,460 bottles of the identical drug, bringing the total to 25,027 bottles impacted. Both recalls were triggered for the same reason, according to Healthline.
Why the pills failed
The FDA enforcement notice stated that the pills failed dissolution specification, meaning they are not releasing the medication into the body as intended. Chlorthalidone is a diuretic, commonly used to treat high blood pressure, fluid retention, heart failure, and diabetes insipidus. Patients are typically instructed to take the pill at breakfast to prevent sleep disruption.
Affected batches and next steps
Three batches of the drug, all expiring in April 2027, are included in the recall. The pills are light yellow and bear the number '103' on one side, while the other side is blank. Specific batch details have been disclosed so patients can contact the pharmacy that dispensed their last prescription to check the batch numbers and determine if they are affected.
